Merck Manual

Please confirm that you are a health care professional

Loading

Hemoglobin E Disease

By

Evan M. Braunstein

, MD, PhD, Johns Hopkins School of Medicine

Last full review/revision Sep 2020| Content last modified Sep 2020
Click here for Patient Education

Homozygous hemoglobin E (Hb E) disease is a hemoglobinopathy that causes a mild hemolytic anemia, usually without splenomegaly.

Hemoglobin (Hb) E is the 3rd most prevalent hemoglobin worldwide (after Hb A and Hb S). It occurs primarily in Southeast Asian (> 15% incidence of homozygous disease) populations, although rarely in people of Chinese descent. Patients who are heterozygous (Hb AE) are asymptomatic. Patients heterozygous for Hb E and beta-thalassemia have a hemolytic disease more severe than hemoglobin S-beta-thalassemia or homozygous Hb E disease and usually have splenomegaly.

In patients who are heterozygous (Hb AE), a microcytosis is present without anemia, and target cells can be seen on peripheral blood smear. In patients who are homozygous, a mild microcytic anemia with prominent target cells exists.

Diagnosis of hemoglobin E disorders is by hemoglobin electrophoresis.

Most patients do not require treatment. However, patients with severe disease may benefit from periodic transfusions or splenectomy.

Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
Professionals also read

Also of Interest

Videos

View All
Bone Marrow Biopsy
Video
Bone Marrow Biopsy
Overview of ADP Receptor
Video
Overview of ADP Receptor
ADP receptors are integral proteins embedded in a platelet membrane. When ADP binds, it causes...

SOCIAL MEDIA

TOP